Owner Illumina, Inc.

Convention US 31 August 2009 77/816,843

Service Davies Collison Cave

Various Convention priority claimed: 31 August 2009, United States of America, No. 77/816,843 in respect of classes 1, 9 & 42 only.

Filing Date 19 February 2010

Class 1 Reagents, reagent kits, beads with attached biomolecules, buffers, and enzymes for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, genes, genomes, sequence variants and modifications, regulation, transcription, and expression, and for studying related associations in the fields of scientific, diagnostic and clinical research

Class 9 Scientific instruments, namely nucleic acid sequencers, imaging devices, and analyzers; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, including arrays, flow cells, beads, bead sets; automated laboratory equipment and systems, including sample loaders and barcode readers; computer systems and software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research

Class 42 Scientific and technological services and research services relating thereto; laboratory services for preparation, detection, quantitation, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; consultancy, information and advisory services relating to the aforesaid services; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules